Cell and Gene Therapy Catapult is a leading Contract Manufacturing Organisation (CMO) and Contract Development and Manufacturing Organisation (CDMO) dedicated to advancing the field of cell and gene therapies. As a supplier to the pharmaceutical industry, the Catapult plays a vital role in accelerating the development and adoption of cutting-edge technology. The company fosters innovation in the life sciences sector, enhancing global competitiveness through its elite technology centres.

Services include:
- Cell and Gene Therapy
- Regulatory Services
- Process Development
- Analytical Development
- Quality Assurance and Quality Control
- Clinical Trial Material Supply

Cell and Gene Therapy Catapult is committed to supporting the biopharmaceutical industry with their expert services and solutions. For more information, please visit ct.catapult.org.uk.